EnGeneIC publishes the COVID-EDV vaccine's novel mechanism
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect
Frontiers | Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
EnGeneIC initiates Phase I trial of nanocellular anti-Covid-19 vaccine
Frontiers | Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Frontiers | Targeting EGFR in Esophagogastric Cancer
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect
Nanocell COVID-19 vaccine elicits potent neutralizing response
Nanocell COVID-19 vaccine elicits potent neutralizing response
Improved Tumor Infiltration and Immunomodulation for Tumor Therapy: A Pathway Based on Tetrahedral Framework Nucleic Acids Coupled Bacterial Nanocells | Nano Letters
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma | Molecular Medicine | Full Text
The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection | SpringerLink
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
Bacteria and bacterial derivatives as drug carriers for cancer therapy - ScienceDirect
Polymers | Free Full-Text | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
EDV Nanocells for Recurrent, Metastatic Pancreatic Cancer Paper to be presented at ASCO - IndiaMedToday
Australia's EnGeneIC receives $10M in Series B round for studies of anticancer delivery tech | Fierce Pharma
Nanocell COVID-19 vaccine elicits potent neutralizing response
Frontiers | Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Polymers | Free Full-Text | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect
Researchers Find A New Way To Target Neuroblastoma | CCI
Biotechs to advance nanocell tech for cancer treatment and COVID-19 vaccine
Polymers | Free Full-Text | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
